ARCHIVES

FDA Approves Rituxan For NHL With CHOP Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 2 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

UPCI Recruits Shin To Lead Head & Neck Cancer Program.

April 27, 2001

Complete List of Recommendations by Centers Committee

October 18, 1996

In Brief: Peter Pisters named CEO of University Health Network in Toronto

August 8, 2014

House, Senate Reform Bills Move Closer To Floor Vote

August 12, 1994

LDK378 Demonstrates 58 Percent Overall Response Rate in Phase I

April 25, 2014

Final Issue of ‘78

December 15, 1978